Q1 2026 Earnings Call May 26, 2026 8:30 AM EDTCompany ParticipantsLisa Conte - Founder, CEO, President & DirectorCarol ...

Novo Nordisk (NVO) stock gains attention as European regulators recommend oral Wegovy approval, marking a first for oral ...

Did you know you could save money on medication every time you need to buy tablets? There's a simple trick and the key lies ...

As generic versions of its blockbuster drug Ofev (nintedanib) start to hit the market, Boehringer Ingelheim GmbH looks to have swerved the patent cliff, with European and Japanese regulators both ...

Discover how konjac glucomannan influences appetite, cholesterol, blood sugar, and gut microbiota while emerging research uncovers its growing role in obesity management and metabolic health.

The global CGRP inhibitors market is expanding rapidly, expected to be valued at around US$ 6.5 billion in 2026 and projected to reach US$ 12.5 billion by 2033, with a CAGR of 9.7% in the coming years ...

The move assumes significance in the backdrop of the government setting a disinvestment and asset monetisation target of ...

Bliss GVS Pharma stock hit a record high of Rs 381.10, up 20 per cent today against the previous close of Rs 317.60 on BSE.

Reflecting continuing concerns over medicine quality and regulatory compliance in India's pharmaceutical market, the Central ...

Anupam Rasayan India Ltd reported a 40 percent rise in consolidated net profit at Rs 222.19 crore for 2025-26, compared with ...

Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.

The United States leads the world in pharmaceutical innovation, with research and development expenditures of over $103 ...